Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding
- Conditions
- Endometrial Disorder
- Registration Number
- NCT03351673
- Lead Sponsor
- Mansoura University
- Brief Summary
Endometrial thickness has been used as an indicator of risk for endometrial hyperplasia and carcinoma in asymptomatic perimenopausal women. However, there is no cutoff value in perimenopausal women and the same thickness does not express the same endometrial volume in different endometrium because uterine lengths may be different and endometrial irregularities may exist. Many studies assessed endometrial volume measured by three-dimensional (3D) TVS as a predictor of malignancy in women with postmenopausal bleeding. To our knowledge there is no study assess endometrial volume measured by two dimension TVS in prediction of endometrial pathology, however it is cheap and available than 3D TVS.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 100
*perimenopausal women with abnormal bleeding e.g. menorrhagia, metrorrhagia and polymenorrhea.
*general or local causes of bleeding, drug intake or recent hormonal contraception
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method accuracy of measurement of endometrial volume by 2D TVS in prediction of endometrial pathology 1year
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
mansoura University
🇪🇬Mansourah, Dakahlia, Egypt
mansoura University🇪🇬Mansourah, Dakahlia, Egypthanan nabil, MDContact00201000571004hanannobil00@yahoo.comwaleed Elrefaie, MDContact00201224515318wrefaie@yahoo.comMahmoud Abdelrazik, MDSub Investigator